ホーム>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>(+)-Penbutolol ((R)-Penbutolol)

(+)-Penbutolol ((R)-Penbutolol) (Synonyms: (R)-Penbutolol; (+)-Isopenbutolol)

カタログ番号GC31597

(+)-ペンブトロール ((R)-ペンブトロール) は、β-アドレナリン受容体拮抗薬であり、IC50 は 0.74 μM.

Products are for research use only. Not for human use. We do not sell to patients.

(+)-Penbutolol ((R)-Penbutolol) 化学構造

Cas No.: 38363-41-6

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$151.00
在庫あり
5mg
$138.00
在庫あり
10mg
$220.00
在庫あり
50mg
$689.00
在庫あり
100mg
$1,103.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2].

(+)-penbutolol on the [Ca2+]i-increase induced by LPC is concentration-dependent[1].(+)-penbutolol inhibits the rounding of cells dose dependently (8±4%, 56±4% and 66±2% at the concentrations of 10-6 M, 5×10-6 M and 10-5 M, respectively)[2].

[1]. Chen M, et al. Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes. Br J Pharmacol. 1996 Jun;118(4):865-70. [2]. Hashizume H, et al. Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes. Eur J Pharmacol. 1994 Dec 12;271(1):1-8.

レビュー

Review for (+)-Penbutolol ((R)-Penbutolol)

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (+)-Penbutolol ((R)-Penbutolol)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.